细胞因子在肺纤维化形成中的作用及对治疗方法的启迪
被引量:2
摘要
肺纤维化是以慢性进行性弥漫性肺间质纤维化和限制性通气功能障碍为特点的肺间质性疾病。在早期为肺泡炎 ,最终导致不可逆性肺纤维化。
出处
《实用心脑肺血管病杂志》
2001年第2期114-117,共4页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
参考文献20
-
1[1]Madtes DK,Elston AL,Hackman RL,et al. Transforming groth factor-alpha deficiency reduced pulmonary fibrosis in transgenic mice. Am J Respir Cell Mol Biol. 1999,20(5):924~934.
-
2[2]Li H,He B,Que I,et al. Expression of TGF-β-1,PDGF and IGF-1 mRNA in lung of bleomycin-A5-induced pulmonary fibrosis in rats. Chin Med J. 1996,109:533~536.
-
3[3]Brass DM,Hoyle GW,Poovey HG,et al. Reduced tumor necrosis factor-α and transforming growth factor-β 1 expression in the lungs of inbred mice that fail to develop fibroproliferative lesions consequent to asbestos exposure. Am J Pathol. 1999,154(3) :853~862.
-
4[4]Maiscalno WM,Villiam M ,Robert A,et al. Transforming growth factor-β1 modulates type Ⅱ cell fibronectin and sufactant proteinc expression. Am J Physiol. 1994,267 :L569~L577.
-
5[5]Wang Q,Wang Y,Hyde DM,et al. Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters. Thorax. 1999,54(90):805~812.
-
6[6]Sime PJ,Marr RA,Gauldie D,et al. Transfor of tumor necrosis factor-α to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-β 1 and myofibroblasts. Am J Pathol. 1998, 153(3):825~832.
-
7[7]Piguet PF, Vesin C. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Respir J. 1994,7(3):515~518.
-
8[8]Lasky JA,Tonthat B,Liu JY,et al. Up regulation of PDGF-alpha receptor precedes asbestos induced lung fibrosis in rat. Am j Respir Crit Care Med. 1998,157:1652 ~ 1657.
-
9[9]Melleni B,Lesur O,Bouhadiba T,et al. Effect of exposure to silica on human AM in supporting growth activity in type Ⅱ epithelial cells. Thorax. 1996,51: 781 ~786.
-
10[10]Koracs EJ, Dipietro LA. Fibrogenic cytokines and connective tissue production. FASEBJ. 1994,8:854~864.
同被引文献16
-
1刘锡琎,郭英兰,俞永信,曾纬.冬虫夏草菌无性阶段的分离和鉴定[J].真菌学报,1989,8(1):35-39. 被引量:107
-
2沈南英 曾璐 张显耻 等.冬虫夏草真菌的分离.食用菌,1983,(5):1-1.
-
3Douglas W W, Ryu J H, Schroeder D R. Idiopathic pulmonary fibrosis: impact of oxygen and colchicine, prednisone, or no therapy on survival[ J]. Am J Respir Crit Care Med,2000,161 (4 Pt 1) :1172.
-
4Raghu G, Weycker D, Edelsberg J, et al. Incidence and preva- lence of idiopathic pulmonary fibrosis[ J]. Am J Respir Crit Care Med,2006,174(7) :810.
-
5Waher N, Collard H R, King T E Jr, et al. Current perspectives on the treatment of idiopathic pulmonary fibrosis [ J ]. Proc Am Thorac Soc,2006,3 (4) :330.
-
6Gao J, Huang Y, Li P, et al. Antifibrosis effects of total gluco- sides of Danggui-Buxue-Tang in a rat model of bleomycin-induced pulmonary fibrosis [ J]. J Ethnopharmacol, 2011,136( 1 ) :21.
-
7Szapiel S V, Elson N A, Fulmer J D, et al. Bleomycin induced interstitial pulmonary disease in the nude, athymic mouse [ J ]. Am Rev Respir Dis, 1979,120 (4) :893.
-
8Gross T J, Hunninghake G W. Idiopathic pulmonary fibrosis[ J]. N Engl J Med, 2001,345 (7) :517.
-
9Vasakova M, Striz I, Slavcev A, et al. Th1/Th2 cytokine gene polymorphisms in patients with idiopathic pulmonary fibrosis [ J]. Tissue Antigens, 2006, 67 (3) :229.
-
10Bergeron A, Soler P, Kambouchner M, et al. Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL-10 [J]. Eur Respir J,2003,22( 1 ) :69.
引证文献2
-
1陈靖,柴瑞华.活络化痰法对肺间质纤维化影响的实验研究[J].山西中医,2007,23(6):57-58. 被引量:4
-
2寿旗扬,傅惠英,张利棕,蔡月琴,陈方明,陈民利.中国被毛孢菌丝体对特发性肺纤维化大鼠的治疗及作用机制研究[J].中国中药杂志,2012,37(23):3618-3623. 被引量:4
二级引证文献8
-
1赵磊,毕丽鑫,王辉.中西医结合疗法治疗间质性肺疾病的疗效观察[J].临床合理用药杂志,2013,6(6):65-65. 被引量:11
-
2李莹莹,朱雪,郭俊美,郑建,王丽芹,杨景青,张伟.浅析痰浊对肺纤维化发生发展的影响[J].中医药信息,2013,30(5):1-3. 被引量:10
-
3苏鑫,汪勤.中药干预肺间质纤维化的实验研究概况[J].吉林中医药,2014,34(1):101-104. 被引量:1
-
4李佩,张伟.从气虚阐述肺纤维化的病机变化[J].江苏中医药,2014,46(9):12-13. 被引量:13
-
5徐华,夏彬,欧阳玉珍,陈莉,曾美群,李芳,谢小艳.丹参酮ⅡA通过iNOS缓解小鼠肺纤维化[J].基础医学与临床,2016,36(8):1113-1117. 被引量:14
-
6葛春蕾,张兴彩,李珂珂.单味中药及其提取物在肺纤维化治疗中的研究进展[J].中医药学报,2020,48(6):67-72. 被引量:18
-
7Li Lu,Haiyan Zhu,Hailin Wang,Huaping Liang,Yayi Hou,Huan Dou.H.sinensis mycelium inhibits epithelial–mesenchymal transition by inactivating the midkine pathway in pulmonary fibrosis[J].Frontiers of Medicine,2021,15(2):313-329. 被引量:5
-
8练东银,贺媛,徐丹,钱正明,李润峰,杨子峰.冬虫夏草在肺部疾病中的潜在作用和研究进展[J].今日药学,2024,34(10):749-760. 被引量:5
-
1邵长周,陈小东,蔡映云.细胞因子在肺纤维化形成中的作用[J].国外医学(内科学分册),2001,28(11):484-487. 被引量:20
-
2谭漪,董滟,董慧君.肺间质纤维化的中医治法[J].四川中医,2008,26(5):19-20. 被引量:3
-
3于露,刘跃建.肿瘤坏死因子-α及转化生长因子-β1在肺纤维化形成中的作用研究进展[J].实用医院临床杂志,2012,9(3):163-165. 被引量:35
-
4杨丽.浅谈特发性肺间质纤维化的辨证论治[J].内蒙古中医药,2011,30(10):125-125. 被引量:6
-
5杨荣泽,傅祖植,严棠.肾素血管紧张素系统与糖尿病肾病[J].国外医学(内科学分册),1993,20(8):340-343.
-
6胡萍,高占成.间质性肺疾病的发病机制[J].国际呼吸杂志,2009,29(14):854-859. 被引量:1
-
7孟哲.弥散性血管内凝血的研究进展[J].中国小儿血液,2001,6(2):88-91. 被引量:1
-
8王学谦,王今达.血小板激活因子在肺间质性疾病中的作用[J].天津医药,1997,25(11):697-700. 被引量:1
-
9古力卡德尔,阿迪娜,赵静,王丽霞,雍楠.特发性肺间质纤维化17例误诊分析[J].陕西医学杂志,2011,40(2):195-195.
-
10李卫青,廖文生,禤少敏,胡清顺,马全庆,赖伟娇.COPD稳定期患者血清HA、LN、PC Ⅲ含量与BODE指数的关系[J].山西中医,2012,28(10):47-50. 被引量:2